INTERPARFUMS INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 DRAFT FOR IMMEDIATE RELEASE INTERPARFUMS, INC. AND MARQUEE BRANDS EXTEND ROBERTO CAVALLI FRAGRANCE PARTNERSHIP FOR 20 YEARS Agreement extends exclusive worldwide license for Roberto Cavalli and Just Cavalli fragrances through 2046 New York, New York, September 17, 20
Interparfums (IPAR) held its annual meeting, adding two luxury industry experts to its board. The refreshed board may influence licensing and branding strategies. Analysts project $1.8B revenue and $184.4M earnings by 2029, with a 12% potential upside. Key risks include license concentration and retailer destocking.
INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Exhibit 99.1 FOR IMMEDIATE RELEASE Interparfums, Inc. Elects Two New Board Members and Announces Annual Meeting Results New York, New York, September 15, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced the results of the matters voted
Over the past 7 days, AlphAI's AI scored 2 news stories mentioning IPAR (INTERPARFUMS INC). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.
Recent IPAR coverage spans earnings, corporate actions and financial news.
In the last 30 days, IPAR insiders filed 1 SEC Form 4 transaction — no purchases and 1 sale ($105K). The most active reporter was Gabai-Pinsky Veronique with 1 filing.
The long‑term license extension secures a key luxury fragrance brand, likely supporting revenue stability and growth for Interparfums.
Interparfums (IPAR) held its annual meeting, adding two luxury industry experts to its board. The refreshed board may influence licensing and branding strategies. Analysts project $1.8B revenue and $184.4M earnings by 2029, with a 12% potential upside. Key risks include license concentration and retailer destocking.
Board composition change may influence future strategic direction but no immediate financial impact.
Interparfums SA reported H1 2026 sales of €414.29M and net income of €65.46M, both down from the prior year. EPS from continuing operations was €0.7429, lower than €0.8312 a year earlier. The results raise concerns about profitability, cost control, and demand trends. The stock trades at a P/E of 20.9x, above the European personal products group average. Analysts' fair value estimates range from €28.70 to €36.25 per share.
Interparfums' shares rose after analysts upgraded ratings and price targets. CIC increased its target to €30 and changed its stance to 'hold', while Berenberg set a €35 target with a positive view. The company reported H1 revenue of €414.3M, down 7.3% YoY, but maintained a 67.3% gross margin and an annual revenue target of €850M-€870M.
AlphAI scores every news story that mentions IPAR with an AI model for sentiment and relevance, and aggregates insider trades from INTERPARFUMS INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
INTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Other Events. Exhibit 99.1 DRAFT FOR IMMEDIATE RELEASE INTERPARFUMS, INC. AND MARQUEE BRANDS EXTEND ROBERTO CAVALLI FRAGRANCE PARTNERSHIP FOR 20 YEARS Agreement extends exclusive worldwide license for Roberto Cavalli and Just Cavalli fragrances through 2046 New York, New York, September 17, 20
2 min readInterparfums (IPAR) held its annual meeting, adding two luxury industry experts to its board. The refreshed board may influence licensing and branding strategies. Analysts project $1.8B revenue and $184.4M earnings by 2029, with a 12% potential upside. Key risks include license concentration and retailer destocking.
2 min readINTERPARFUMS INC (IPAR) filed an SEC Form 8-K — Submission of Matters to a Vote of Security Holders. Exhibit 99.1 FOR IMMEDIATE RELEASE Interparfums, Inc. Elects Two New Board Members and Announces Annual Meeting Results New York, New York, September 15, 2026, Interparfums, Inc. (NASDAQ GS: IPAR) (“Interparfums” or the “Company”) today announced the results of the matters voted
1 min readInterparfums SA reported H1 2026 sales of €414.29M and net income of €65.46M, both down from the prior year. EPS from continuing operations was €0.7429, lower than €0.8312 a year earlier. The results raise concerns about profitability, cost control, and demand trends. The stock trades at a P/E of 20.9x, above the European personal products group average. Analysts' fair value estimates range from €28.70 to €36.25 per share.
2 min readInterparfums' shares rose after analysts upgraded ratings and price targets. CIC increased its target to €30 and changed its stance to 'hold', while Berenberg set a €35 target with a positive view. The company reported H1 revenue of €414.3M, down 7.3% YoY, but maintained a 67.3% gross margin and an annual revenue target of €850M-€870M.
1 min readEuronext Paris has added Genfit and Inventiva to its SBF120 index, while Interparfums and Verallia have been excluded. The changes reflect the latest review of the index composition, which tracks the performance of the 120 most significant stocks on the Euronext Paris market.
1 min readNature's Sunshine (NYSE:USNA) reported $117M revenue, up 1.9% YoY, missing estimates. Herbalife (NYSE:HLF) reported $1.33B revenue, up 5.4%, beating estimates. Inter Parfums (NASDAQ:IPAR) reported $341M revenue, up 2.1%, beating estimates. All three stocks declined since earnings.
3 min readGabai-Pinsky Veronique sold 900 shares of INTERPARFUMS INC (IPAR) at $116.86 ($0.11M total) on 2026-08-27.
1 min readInterparfums (IPAR) received a Zacks Rank #2 (Buy) upgrade due to higher earnings estimates. Analysts highlight the company's steady dividend, buyback program, and potential from new fragrance licenses. However, investors should consider risks like margin pressure and valuation concerns.
2 min readInterparfums (IPAR) was upgraded to a Zacks Rank #2 (Buy) due to upward trends in earnings estimates, which often correlate with stock price movements. The upgrade reflects positivity about the company's earnings outlook, potentially leading to increased buying pressure and stock price appreciation. The Zacks rating system is based on changes in earnings estimates and has a strong track record of predicting stock performance.
2 min read
